MGRX
Mangoceuticals, Inc. Common Stock
NASDAQ: MGRX · HEALTHCARE · HEALTH INFORMATION SERVICES
$0.34
+2.56% today
Updated 2026-04-30
Market cap
$6.79M
P/E ratio
—
P/S ratio
14.88x
EPS (TTM)
$-2.17
Dividend yield
—
52W range
$0 – $3
Volume
15.5M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+4.5
Quality
C2.5
Profitability
F5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-0.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -0.51 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.08M
- Revenue declining -10.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $8939.00 | $731493.00 | $615873.00 | $456021.00 | $456020.00 |
| Net income | $-2.00M | $-9.21M | $-8.71M | $-20.64M | $-2.77M |
| EPS | — | — | — | — | $-2.17 |
| Free cash flow | $-1.39M | $-7.00M | $-4.86M | $-5.85M | $-1.08M |
| Profit margin | -22,352.11% | -1,259.40% | -1,413.60% | -4,526.86% | — |
Peer comparison
Smart narrative
Mangoceuticals, Inc. Common Stock trades at $0.34. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -0.51, it sits in the distress. TTM revenue stands at $456020.00.
Frequently asked questions
What is Mangoceuticals, Inc. Common Stock's stock price?
Mangoceuticals, Inc. Common Stock (MGRX) trades at $0.34.
Is Mangoceuticals, Inc. Common Stock overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Mangoceuticals, Inc. Common Stock (MGRX)?
The analyst target price is $—, representing NaN% downside from the current price of $0.34.
What is Mangoceuticals, Inc. Common Stock's revenue?
TTM revenue is $456020.00.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-0.51 — distress.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio14.88x
ROE-141.70%
Beta2.55
50D MA$0.40
200D MA$1.24
Shares out0.02B
Float0.01B
Short ratio—
Avg volume15.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—